JANX Competitors & Alternatives
Compare Janux Therapeutics Inc with similar stocks in the same industry
Biotechnology
JANX
Main Stock$17.10
Tradestie Score
41
Market Cap
$1.42B
Revenue Growth
21.8%
Analyst Upside
+111.9%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INVA
Innoviva, Inc. Common Stock
|
$20.66
|
$1.15B | 4.9 | 44 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$15.90
|
$1.14B | - | 56 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$12.04
|
$1.14B | - | 49 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$24.60
|
$1.13B | - | 45 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$4.59
|
$1.12B | - | 41 | Compare |
|
NKTR
Nektar Therapeutics
|
$69.76
|
$1.12B | - | 56 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$334.58
|
$1.12B | - | 51 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$8.79
|
$1.09B | - | 43 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$11.21
|
$1.05B | 77.2 | 42 | Compare |
|
MDXG
MiMedx Group, Inc
|
$4.57
|
$1.01B | 115.0 | 47 | Compare |
More JANX Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry